Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: Jaidev Sharma who wrote (833)	11/12/1998 7:05:00 PM
From: vestor	Read Replies (1) \| Respond to of 1837

I could not find any projected earnings... It appears that the health of DRMD is getting better... Cenestin is still the key to sucess here and what is very important is that they now have the credit line to implement/tool up for the production of Cenestin ...... It appears that based on the statement the CEO made about the progress Cenestin has made at the FDA there must a way we can find out that same info.... any ideas..... It could be worth zillions !!!!